A multifunctional theranostic platform based on phthalocyanine-loaded dendrimer for image-guided drug delivery and photodynamic therapy

Molecular Pharmaceutics

Volumn 10, Issue 10, 2013, Pages 3946-3958

  Taratula, Oleh ^a   Schumann, Canan ^a   Naleway, Michael A ^a   Pang, Addison J ^a   Chon, Kaitlyn J ^a   Taratula, Olena ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Cancer therapy; Dendrimer; Drug delivery; Photodynamic therapy; Phthalocyanines; Theranostics

Indexed keywords

AMINE; DENDRIMER; GONADORELIN; MACROGOL; NANOCARRIER; PHOTOSENSITIZING AGENT; PHTHALOCYANINE; POLYMER; POLYPROPYLENIMINE GENERATION 4; REACTIVE OXYGEN METABOLITE; SILICON; THERANOSTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CANCER CELL; CANCER THERAPY; CARBON NUCLEAR MAGNETIC RESONANCE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; ENCAPSULATION; FLUORESCENCE; FLUORESCENCE IMAGE GUIDED DRUG DELIVERY; HUMAN; HUMAN CELL; HYDROPHOBICITY; INTERNALIZATION; IRRADIATION; LIGHT; OPTICS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TARGET CELL; THERANOSTICS;

DENDRIMERS; DRUG DELIVERY SYSTEMS; GONADOTROPIN-RELEASING HORMONE; INDOLES; PHOTOCHEMOTHERAPY;

EID: 84888373686     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400397t     Document Type: Article

References (50)

1. Josefsen, L. B.; Boyle, R. W. Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics. Theranostics 2012, 2, 916-966.
2. Huang, P.; Lin, J.; Wang, X. S.; Wang, Z.; Zhang, C. L.; He, M.; Wang, K.; Chen, F.; Li, Z. M.; Shen, G. X.; Cui, D. X.; Chen, X. Y. Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy. Adv. Mater. 2012, 24, 5104-5110.
3. Choi, K. Y.; Liu, G.; Lee, S.; Chen, X. Y. Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. Nanoscale 2012, 4, 330-342.
4. Huang, P.; Lin, J.; Wang, S. J.; Zhou, Z. J.; Li, Z. M.; Wang, Z.; Zhang, C. L.; Yue, X. Y.; Niu, G.; Yang, M.; Cui, D. X.; Chen, X. Y. Photosensitizer-conjugated silica-coated gold nanoclusters for fluorescence imaging-guided photodynamic therapy. Biomaterials 2013, 34, 4643-4654.
5. Agostinis, P.; Berg, K.; Cengel, K. A.; Foster, T. H.; Girotti, A. W.; Gollnick, S. O.; Hahn, S. M.; Hamblin, M. R.; Juzeniene, A.; Kessel, D.; Korbelik, M.; Moan, J.; Mroz, P.; Nowis, D.; Piette, J.; Wilson, B. C.; Golab, J. Photodynamic therapy of cancer: an update. Ca-Cancer J. Clin. 2011, 61, 250-281.
6. Dolmans, D. E.; Fukumura, D.; Jain, R. K. Photodynamic therapy for cancer. Nat. Rev. Cancer 2003, 3, 380-387.
7. Wilson, B. C.; Patterson, M. S. The physics, biophysics and technology of photodynamic therapy. Phys. Med. Biol. 2008, 53, R61-R109.
8. MacDonald, I. J.; Dougherty, T. J. Basic principles of photodynamic therapy. J. Porphyrins Phthalocyanines 2001, 5, 105-129.
9. Sharman, W. M.; Allen, C. M.; van Lier, J. E. Photodynamic therapeutics: basic principles and clinical applications. Drug Discovery Today 1999, 4, 507-517.
10. Sekkat, N.; van den Bergh, H.; Nyokong, T.; Lange, N. Like a bolt from the blue: phthalocyanines in biomedical optics. Molecules 2012, 17, 98-144.
11. Pansare, V. J.; Hejazi, S.; Faenza, W. J.; Prud'homme, R. K. Review of long-wavelength optical and NIR imaging materials: contrast agents, fluorophores, and multifunctional nano carriers. Chem. Mater. 2012, 24, 812-827.
12. Bugaj, A. M. Targeted photodynamic therapy-A promising strategy of tumor treatment. Photochem. Photobiol. Sci. 2011, 10, 1097-1109.
13. Shao, J. W.; Dai, Y. C.; Zhao, W. N.; Xie, J. J.; Xue, J. P.; Ye, J. H.; Jia, L. Intracellular distribution and mechanisms of actions of photosensitizer Zinc(II)-phthalocyanine solubilized in Cremophor EL against human hepatocellular carcinoma HepG2 cells. Cancer Lett. 2013, 330, 49-56.
14. Lu, H. L.; Syu, W. J.; Nishiyama, N.; Kataoka, K.; Lai, P. S. Dendrimer phthalocyanine-encapsulated polymeric micelle-mediated photochemical internalization extends the efficacy of photodynamic therapy and overcomes drug-resistance in vivo. J. Controlled Release 2011, 155, 458-464.
15. Garcia, A. M.; Alarcon, E.; Munoz, M.; Scaiano, J. C.; Edwards, A. M.; Lissi, E. Photophysical behaviour and photodynamic activity of zinc phthalocyanines associated to liposomes. Photochem. Photobiol. Sci 2011, 10, 507-514.
16. Cui, S. S.; Yin, D. Y.; Chen, Y. Q.; Di, Y. F.; Chen, H. Y.; Ma, Y. X.; Achilefu, S.; Gu, Y. Q. In vivo targeted deep-tissue photodynamic therapy based on near-infrared light triggered upconversion nanoconstruct. ACS Nano 2013, 7, 676-688.
17. Guo, H. C.; Qian, H. S.; Idris, N. M.; Zhang, Y. Singlet oxygeninduced apoptosis of cancer cells using upconversion fluorescent nanoparticles as a carrier of photosensitizer. Nanomedicine 2010, 6, 486-495.
18. Mitsunaga, M.; Ogawa, M.; Kosaka, N.; Rosenblum, L. T.; Choyke, P. L.; Kobayashi, H. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat. Med. 2011, 17, 1685-U210.
19. Cheng, Y. Y.; Xu, Z. H.; Ma, M. L.; Xu, T. W. Dendrimers as drug carriers: Applications in different routes of drug administration. J. Pharm. Sci. 2008, 97, 123-143.
20. Medina, S. H.; El-Sayed, M. E. H. Dendrimers as carriers for delivery of chemotherapeutic agents. Chem. Rev. 2009, 109, 3141. 3157.
21. Jang, W. D.; Nakagishi, Y.; Nishiyama, N.; Kawauchi, S.; Morimoto, Y.; Kikuchi, M.; Kataoka, K. Polyion complex micelles for photodynamic therapy: Incorporation of dendritic photosensitizer excitable at long wavelength relevant to improved tissue-penetrating property. J. Controlled Release 2006, 113, 73-79.
22. Wolinsky, J. B.; Grinstaff, M. W. Therapeutic and diagnostic applications of dendrimers for cancer treatment. Adv. Drug Delivery Rev. 2008, 60, 1037-1055.
23. Lo, S. T.; Kumar, A.; Hsieh, J. T.; Sun, X. K. Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry. Mol. Pharmaceutics 2013, 10, 793-812.
24. Kojima, C.; Toi, Y.; Harada, A.; Kono, K. Preparation of poly(ethylene glycol)-attached dendrimers encapsulating photosensitizers for application to photodynamic therapy. Bioconjugate Chem. 2007, 18, 663-670.
25. Taratula, O.; Garbuzenko, O. B.; Chen, A. M.; Minko, T. Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA. J. Drug Targeting 2011, 19, 900-914.
26. Kannaiyan, D.; Imae, T. pH-dependent encapsulation of pyrene in PPI-core:PAMAM-shell dendrimers. Langmuir 2009, 25, 5282-5285.
27. Wang, F.; Cai, X. P.; Su, Y. Z.; Hu, J. J.; Wu, Q.; Zhang, H. F.; Xiao, J. R.; Cheng, Y. Y. Reducing cytotoxicity while improving anticancer drug loading capacity of polypropylenimine dendrimers by surface acetylation. Acta Biomater. 2012, 8, 4304-4313.
28. Taratula, O.; Garbuzenko, O.; Savla, R.; Wang, Y. A.; He, H. X.; Minko, T. Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticlesdendrimer complexes. Curr. Drug Delivery 2011, 8, 59-69.
29. Taratula, O.; Garbuzenko, O. B.; Kirkpatrick, P.; Pandya, I.; Savla, R.; Pozharov, V. P.; He, H. X.; Minko, T. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. J. Controlled Release 2009, 140, 284-293.
30. Dharap, S. S.; Minko, T. Targeted proapoptotic LHRH-BH3 peptide. Pharm. Res. 2003, 20, 889-896.
31. Taratula, O.; Kuzmov, A.; Shah, M.; Garbuzenko, O. B.; Minko, T. Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. J. Controlled Release 2013, DOI: 10.1016/j.jconrel.2013-04.018.
32. Yildirim, A.; Ozgur, E.; Bayindir, M. Impact of mesoporous silica nanoparticle surface functionality on hemolytic activity, thrombogenicity and non-specific protein adsorption. J. Mater. Chem. B 2013, 1, 1909-1920.
33. Kimani, S. G.; Shmigol, T. A.; Hammond, S.; Phillips, J. B.; Bruce, J. I.; MacRobert, A. J.; Malakhov, M. V.; Golding, J. P. Fully protected glycosylated zinc (II) phthalocyanine shows high uptake and photodynamic cytotoxicity in MCF-7 cancer cells. Photochem. Photobiol. 2013, 89, 139-149.
34. Savla, R.; Taratula, O.; Garbuzenko, O.; Minko, T. Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. J. Controlled Release 2011, 153, 16. 22.
35. Durmus, M.; Yesilot, S.; Ahsen, V. Separation and mesogenic properties of tetraalkoxy-substituted phthalocyanine isomers. New J. Chem. 2006, 30, 675-678.
36. Dayal, S.; Li, J.; Li, Y. S.; Wu, H. Q.; Samia, A. C. S.; Kenney, M. E.; Burda, C. Effect of the functionalization of the axial phthalocyanine ligands on the energy transfer in QD-based donor-acceptor pairs. Photochem. Photobiol. 2008, 84, 243-249.
37. Lau, J. T. F.; Lo, P. C.; Fong, W. P.; Ng, D. K. P. Preparation and photodynamic activities of silicon(IV) phthalocyanines substituted with permethylated beta-cyclodextrins. Chem.-Eur. J. 2011, 17, 7569-7577.
38. Wagner, J. R.; Ali, H.; Langlois, R.; Brasseur, N.; Vanlier, J. E. Biological-activities of phthalocyanines-VI. Photooxidation of Ltryptophan by selectively sulfonated gallium phthalocyanines-singlet oxygen yields and effect of aggregation. Photochem. Photobiol. 1987, 45, 587-594.
39. Spikes, J. D.; Bommer, J. C. Zinc tetasulphophthalocyanine as a photodynamic sensitizer for biomolecules. Int. J. Radiat. Res. 1986, 41-47.
40. Kojima, C.; Kono, K.; Maruyama, K.; Takagishi, T. Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjugate Chem. 2000, 11, 910-917.
41. Alexis, F.; Pridgen, E.; Molnar, L. K.; Farokhzad, O. C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharmaceutics 2008, 5, 505-515.
42. Allen, T. M.; Cullis, P. R. Drug delivery systems: Entering the mainstream. Science 2004, 303, 1818-1822.
43. Dharap, S. S.; Wang, Y.; Chandna, P.; Khandare, J. J.; Qiu, B.; Gunaseelan, S.; Sinko, P. J.; Stein, S.; Farmanfarmaian, A.; Minko, T. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 12962-12967.
44. Nagy, A.; Schally, A. V. Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers. Biol. Reprod. 2005, 73, 851-859.
45. Emons, G.; Pahwa, G. S.; Brack, C.; Sturm, R.; Oberheuser, F.; Knuppen, R. Gonadotropin-Releasing Hormone Binding-Sites in Human Epithelial Ovarian Carcinomata. Eur. J. Cancer Clin. Oncol. 1989, 25, 215-221.
46. Srkalovic, G.; Schally, A. V.; Wittliff, J. L.; Day, T. G.; Jenison, E. L. Presence and characteristics of receptors for [D-Trp(6)]luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer. Int. J. Oncol. 1998, 12, 489-498.
47. Volker, P.; Grundker, C.; Schmidt, O.; Schulz, K. D.; Emons, G. Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: Frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues. Am. J. Obstet. Gynecol. 2002, 186, 171-179.
48. Maruyama, K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv. Drug Delivery Rev. 2011, 63, 161-169.
49. Almeida, R. D.; Manadas, B. J.; Carvalho, A. P.; Duarte, C. B. Intracellular signaling mechanisms in photodynamic therapy. Biochim. Biophys. Acta 2004, 1704, 59-86.
50. Low, K.; Knobloch, T.; Wagner, S.; Wiehe, A.; Engel, A.; Langer, K.; von Briesen, H. Comparison of intracellular accumulation and cytotoxicity of free mTHPC and mTHPC-loaded PLGA nanoparticles in human colon carcinoma cells. Nanotechnology 2011, 22.